You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 291 No. 5, February 4, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (9)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Gastrointestinal Diseases
 •Oncology
 •Colon Cancer
 •Alert me on articles by topic

Is C-Reactive Protein an Inflammation Opsonin That Signals Colon Cancer Risk?

Boris Pasche, MD, PhD; Charles N. Serhan, PhD

JAMA. 2004;291:623-624.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Colorectal cancer is a leading cause of cancer-related morbidity and mortality in the Western world. A personal history of inflammatory bowel disease (IBD) is a well-established risk factor for colorectal cancer. Recent data suggest that the risk of colorectal cancer for individuals with IBD increases by 0.5% to 1.0% yearly, 8 to 10 years after diagnosis.1 The magnitude of colorectal cancer risk increases with early age at IBD diagnosis, longer duration of symptoms, and extent of the disease.1 In addition, a wealth of experimental, epidemiological, and randomized trial evidence suggests that long-term use of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) can reduce the risk of colorectal adenoma and cancer.2-4 In both instances, the duration of either the inflammatory process or the use of anti-inflammatory agents is emerging as a key predictor of increased and decreased colorectal cancer risk, respectively.

In this . . . [Full Text of this Article]

What Would Lead to Elevated CRP Level in Colon Cancer?

Author Affiliations: Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Ill (Dr Pasche). Dr Pasche is a Contributing Editor, JAMA. Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative, and Pain Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass (Dr Serhan).


RELATED ARTICLE

C-Reactive Protein and the Risk of Incident Colorectal Cancer
Thomas P. Erlinger, Elizabeth A. Platz, Nader Rifai, and Kathy J. Helzlsouer
JAMA. 2004;291(5):585-590.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

C-Reactive Protein Levels Are Not Associated with Increased Risk for Colorectal Cancer in Women
Zhang et al.
ANN INTERN MED 2005;142:425-432.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.